This article may have been created or edited in return for undisclosed payments, a violation of Wikipedia's terms of use. It may require cleanup to comply with Wikipedia's content policies, particularly neutral point of view. (February 2024) |
Type of site | cognitive training |
---|---|
Available in | German, English, Spanish, Portuguese, Italian, Russian, French, Polish, Korean, Japanese |
Headquarters | Berlin, Germany |
Created by | Rojahn Ahmadi and Jakob Futorjanski |
URL | www |
Commercial | yes |
Users | 10 million |
Launched | 2011 |
NeuroNation and its associated medical app NeuroNation MED are cognitive training software applications developed by the German healthcare technology company Synaptikon GmbH. [1] [2] [3] NeuroNation was launched in 2011. [4]
The online platform was launched in 2011, and initially served Germany, Austria, and Switzerland. [5] In 2014, Der Spiegel and XLHealth AG bought a 25% stake in NeuroNation, financing an expansion into English, French, Spanish, Italian, Russian, Japanese, and Portuguese markets. [5]
NeuroNation is a multi-modal cognitive training application for prevention of neurodegenerative diseases and cognitive enhancement. [6] [7] NeuroNation MED is a mobile application , developed for users with cognitive impairments that offers multi-domain computerised cognitive training based on gamified exercises. [8] Health literacy is conveyed via in-app resources that give users information on performance enhancement, well-being, and relaxation, in addition to health literacy. [8] NeuroNation is available as a web app via NeuroNation.com, on Android, and iOS devices. [9] [10]
In 2014, NeuroNation was named one of the best "Apps of the Year" by Apple. [11] Its use is reimbursed by all German health insurers as a Digitale Gesundheitsanwendung (DiGA), digital health application, [12] including Deutsche BKK. [13]
The program began with a single-payment model, later shifting to a subscription business model. [14] The app offers some content free, while other activities are available through in-app purchases. [15]
NeuroNation was awarded the Leonardo Health Prize for digital prevention. [16]
In the "Intera-KT" project, NeuroNation collaborated with the Berlin University Hospital Charité and other partners to digitise paper-based cognitive tests. [17]
NeuroNation is currently participating in a study on the effects of independent cognitive training using Neuronation MED on patients with mild cognitive disorders and patients with Post COVID-19 condition. [18]
In several studies, healthy participants who have used NeuroNation as a cognitive training tool have shown positive effects for working memory, memory, and executive functions. [19] [20] [21] One study by MSH Medical School Hamburg and the University of Würzburg observed that subjects who participated in NeuroNation exercises exhibited improved memory, concentration, and general well-being. [19]
The caudate nucleus is one of the structures that make up the corpus striatum, which is a component of the basal ganglia in the human brain. While the caudate nucleus has long been associated with motor processes due to its role in Parkinson's disease, it plays important roles in various other nonmotor functions as well, including procedural learning, associative learning and inhibitory control of action, among other functions. The caudate is also one of the brain structures which compose the reward system and functions as part of the cortico–basal ganglia–thalamic loop.
Cognitive neuropsychiatry is a growing multidisciplinary field arising out of cognitive psychology and neuropsychiatry that aims to understand mental illness and psychopathology in terms of models of normal psychological function. A concern with the neural substrates of impaired cognitive mechanisms links cognitive neuropsychiatry to the basic neuroscience. Alternatively, CNP provides a way of uncovering normal psychological processes by studying the effects of their change or impairment.
The primary goals of stroke management are to reduce brain injury and promote maximum patient recovery. Rapid detection and appropriate emergency medical care are essential for optimizing health outcomes. When available, patients are admitted to an acute stroke unit for treatment. These units specialize in providing medical and surgical care aimed at stabilizing the patient's medical status. Standardized assessments are also performed to aid in the development of an appropriate care plan. Current research suggests that stroke units may be effective in reducing in-hospital fatality rates and the length of hospital stays.
Imaging genetics refers to the use of anatomical or physiological imaging technologies as phenotypic assays to evaluate genetic variation. Scientists that first used the term imaging genetics were interested in how genes influence psychopathology and used functional neuroimaging to investigate genes that are expressed in the brain.
HIV-associated neurocognitive disorders (HAND) are neurological disorders associated with HIV infection and AIDS. It is a syndrome of progressive deterioration of memory, cognition, behavior, and motor function in HIV-infected individuals during the late stages of the disease, when immunodeficiency is severe. HAND may include neurological disorders of various severity. HIV-associated neurocognitive disorders are associated with a metabolic encephalopathy induced by HIV infection and fueled by immune activation of macrophages and microglia. These cells are actively infected with HIV and secrete neurotoxins of both host and viral origin. The essential features of HIV-associated dementia (HAD) are disabling cognitive impairment accompanied by motor dysfunction, speech problems and behavioral change. Cognitive impairment is characterised by mental slowness, trouble with memory and poor concentration. Motor symptoms include a loss of fine motor control leading to clumsiness, poor balance and tremors. Behavioral changes may include apathy, lethargy and diminished emotional responses and spontaneity. Histopathologically, it is identified by the infiltration of monocytes and macrophages into the central nervous system (CNS), gliosis, pallor of myelin sheaths, abnormalities of dendritic processes and neuronal loss.
Memory disorders are the result of damage to neuroanatomical structures that hinders the storage, retention and recollection of memories. Memory disorders can be progressive, including Alzheimer's disease, or they can be immediate including disorders resulting from head injury.
Cognitive reserve is the mind's and brain's resistance to damage of the brain. The mind's resilience is evaluated behaviorally, whereas the neuropathological damage is evaluated histologically, although damage may be estimated using blood-based markers and imaging methods. There are two models that can be used when exploring the concept of "reserve": brain reserve and cognitive reserve. These terms, albeit often used interchangeably in the literature, provide a useful way of discussing the models. Using a computer analogy, brain reserve can be seen as hardware and cognitive reserve as software. All these factors are currently believed to contribute to global reserve. Cognitive reserve is commonly used to refer to both brain and cognitive reserves in the literature.
Brain training is a program of regular activities purported to maintain or improve one's cognitive abilities. The phrase "cognitive ability" usually refers to components of fluid intelligence such as executive function and working memory. Cognitive training reflects a hypothesis that cognitive abilities can be maintained or improved by exercising the brain, analogous to the way physical fitness is improved by exercising the body. Cognitive training activities can take place in numerous modalities such as cardiovascular fitness training, playing online games or completing cognitive tasks in alignment with a training regimen, playing video games that require visuospatial reasoning, and engaging in novel activities such as dance, art, and music.
Post-chemotherapy cognitive impairment (PCCI) describes the cognitive impairment that can result from chemotherapy treatment. Approximately 20 to 30% of people who undergo chemotherapy experience some level of post-chemotherapy cognitive impairment. The phenomenon first came to light because of the large number of breast cancer survivors who complained of changes in memory, fluency, and other cognitive abilities that impeded their ability to function as they had pre-chemotherapy.
Certain treatments for childhood cancer are known to cause learning problems in survivors, particularly when central nervous system (CNS)-directed therapies are used. As the mortality rates of childhood cancers have plummeted since effective treatment regiments have been introduced, greater attention has been paid to the effect of treatment on neurocognitive morbidity and quality of life of survivors. The goal of treatment for childhood cancers today is to minimize these adverse "late effects", while ensuring long-term survival.
Mild cognitive impairment (MCI) is a neurocognitive disorder which involves cognitive impairments beyond those expected based on an individual's age and education but which are not significant enough to interfere with instrumental activities of daily living. MCI may occur as a transitional stage between normal aging and dementia, especially Alzheimer's disease. It includes both memory and non-memory impairments. The cause of the disorder remains unclear, as well as both its prevention and treatment, with some 50 percent of people diagnosed with it going on to develop Alzheimer's disease within five years. The diagnosis can also serve as an early indicator for other types of dementia, although MCI may remain stable or even remit.
Cogmed is a cognitive training software program created in the lab of Torkel Klingberg, a neuroscientist at the Karolinska Institute. Torkel Klingberg was using it to present working memory challenges to people while he studied their brains using fMRI, to try to learn about neuroplasticity. When the studies appeared to show that the challenges improved working memory, Klingberg founded Cogmed in 2001, with financial backing from the Karolinska Institute and venture capitalists.
Memory improvement is the act of enhancing one's memory. Research on improving memory is driven by amnesia, age-related memory loss, and people’s desire to enhance their memory. Research involved in memory improvement has also worked to determine what factors influence memory and cognition. There are many different techniques to improve memory some of which include cognitive training, psychopharmacology, diet, stress management, and exercise. Each technique can improve memory in different ways.
Attentional control, colloquially referred to as concentration, refers to an individual's capacity to choose what they pay attention to and what they ignore. It is also known as endogenous attention or executive attention. In lay terms, attentional control can be described as an individual's ability to concentrate. Primarily mediated by the frontal areas of the brain including the anterior cingulate cortex, attentional control and attentional shifting are thought to be closely related to other executive functions such as working memory.
Lumosity is an online program consisting of games claiming to improve memory, attention, flexibility, speed of processing, and problem solving.
Chronic solvent-induced encephalopathy (CSE) is a condition induced by long-term exposure to organic solvents, often—but not always—in the workplace, that lead to a wide variety of persisting sensorimotor polyneuropathies and neurobehavioral deficits even after solvent exposure has been removed. This syndrome can also be referred to as psycho-organic syndrome, organic solvent syndrome, chronic painter's syndrome, occupational solvent encephalopathy, solvent intoxication, toxic solvent syndrome, painters disease, chronic toxic encephalopathy, or neurasthenic syndrome. The multiple names of solvent-induced syndromes combined with inconsistency in research methods makes referencing this disease difficult and its catalog of symptoms vague.
Neuroenhancement or cognitive enhancement is the experimental use of pharmacological or non-pharmacological methods intended to improve cognitive and affective abilities in healthy people who do not have a mental illness. Agents or methods of neuroenhancement are intended to affect cognitive, social, psychological, mood, or motor benefits beyond normal functioning.
Video game rehabilitation is a process of using common video game consoles and methodology to target and improve physical and mental weaknesses through therapeutic processes. Video games are becoming an integral part of occupational therapy practice in acute, rehabilitation, and community settings. The design for video games in rehabilitation is focused on a number of fundamental principles, such as reward, goals, challenge, and meaningful play. 'Meaningful play' emerges from the relationship between player action and system outcome, apparent to the player through, visual, physical and aural feedback. Platforms that feature motion control, notably the Nintendo Wii, Microsoft's Xbox Kinect, Sony's Eye Toy, and virtual reality have all been effective in this field of research. Methodologies have been applied to all age groups, from toddlers to the elderly. It has been used in a variety of cases ranging from stroke rehabilitation, cerebral palsy and other neurological impairments, to tendinitis and multiple sclerosis. Researchers have promoted such technology based on the personalization of gaming systems to patients, allowing for further engagement and interaction. Additionally, gaming consoles have the ability to capture real-time data and provide instant feedback to the patients using the systems. Currently, several researchers have performed case studies to demonstrate the benefits of this technology. Repeat trials and experiments have shown that outcomes are easily replicated among various groups worldwide. Additionally, the outcomes have increased interest in the field, growing experiments beyond simple case studies to experiments with a larger participant base.
Gait variability seen in Parkinson's Disorders arise due to cortical changes induced by pathophysiology of the disease process. Gait rehabilitation is focused to harness the adapted connections involved actively to control these variations during the disease progression. Gait variabilities seen are attributed to the defective inputs from the Basal Ganglia. However, there is altered activation of other cortical areas that support the deficient control to bring about a movement and maintain some functional mobility.
Georg Winterer is a German entrepreneur, neuroscientist and specialist in psychiatry and psychotherapy. He is an Associate Professor at the Charité – University Medicine Berlin, director of the Neuroimaging Research Group in the Experimental and Clinical Research Center (ECRC) at the Charité – University Medicine Berlin. He is the founder and managing director of the Berlin PI Solutions Group GmbH.